Omalizumab: an anti-IgE antibody binding to CD16 (FcγRIIIa)

被引：0
|
作者：
Oehrl, S. [1 ]
Maas, M. [1 ]
Doebel, T. [1 ]
Meisel, S. [1 ]
Pezer, S. [1 ]
Schaekel, K. [1 ]
机构：
[1] Univ Heidelberg Hosp, Dept Dermatol, D-69120 Heidelberg, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2016年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P151
引用
收藏
页码：E26 / E26
页数：1
相关论文
共 50 条
  • [1] Omalizumab (Xolair):: An anti-IgE antibody for asthma
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1163): : 67 - 68
  • [2] Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa)
    Couzi, Lionel
    Pitard, Vincent
    Sicard, Xavier
    Garrigue, Isabelle
    Hawchar, Omar
    Merville, Pierre
    Moreau, Jean-Francois
    Dechanet-Merville, Julie
    BLOOD, 2012, 119 (06) : 1418 - 1427
  • [3] Current and future applications of the anti-IgE antibody omalizumab
    Incorvaia, Cristoforo
    Mauro, Marina
    Riario-Sforza, Gian Galeazzo
    Frati, Franco
    Tarantini, Francesco
    Caserini, Maurizio
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01): : 67 - 73
  • [4] Role of FcγRIIIA (CD16) in IVIg-Mediated Anti-Inflammatory Function
    Ben Mkaddem, Sanae
    Aloulou, Meryem
    Benhamou, Marc
    Monteiro, Renato C.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S46 - S50
  • [5] Role of FcγRIIIA (CD16) in IVIg-Mediated Anti-Inflammatory Function
    Sanae Ben Mkaddem
    Meryem Aloulou
    Marc Benhamou
    Renato C. Monteiro
    Journal of Clinical Immunology, 2014, 34 : 46 - 50
  • [6] The anti-IgE antibody omalizumab as a probe to investigate the role of IgE in pathology
    Mauro, M.
    Incorvaia, C.
    Formigoni, C.
    Elia, R.
    Russello, M.
    Pellegrino, D.
    PANMINERVA MEDICA, 2012, 54 (04) : 305 - 311
  • [7] Aberrant expression of FcγRIIIA (CD16) contributes to the development of atherosclerosis
    Huang, Ye
    Yin, Huijun
    Wang, Jingshang
    Liu, Qian
    Wu, Caifeng
    Chen, Keji
    GENE, 2012, 498 (01) : 91 - 95
  • [8] Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab
    Davies, Anna M.
    Allan, Elizabeth G.
    Keeble, Anthony H.
    Delgado, Jean
    Cossins, Benjamin P.
    Mitropoulou, Alkistis N.
    Pang, Marie O. Y.
    Ceska, Tom
    Beavil, Andrew J.
    Craggs, Graham
    Westwood, Marta
    Henry, Alistair J.
    McDonnell, James M.
    Sutton, Brian J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (24) : 9975 - 9987
  • [9] Omalizumab (an Anti-IgE Antibody) in the Treatment of Severe Atopic Eczema
    Ramirez Del Pozo, M. E.
    Contreras Contreras, E.
    Lopez Tiro, J.
    Gomez Vera, J.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2011, 21 (05) : 416 - 417
  • [10] A novel mutation in the FcγRIIIA gene (CD16) results in active natural killer cells lacking CD16
    Takeuchi, T
    Nakagawa, T
    Ikemoto, T
    Sasaki, M
    Makino, S
    Shimizu, A
    Ohsawa, N
    AUTOIMMUNITY, 1999, 31 (04) : 265 - 271
12345